[1]何升华 赖居易 冯华龙.脊康方在经皮腰椎间孔镜围手术期运用的临床研究[J].中国中医骨伤科杂志,2018,26(02):18-22.
　HE Shenghua LAI Juyi FENG Hualong.Clinical Study of Jikang Decoction for Patients with Percutaneous Endoscopic Lumbar Discectomy in Period of Perioperative[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2018,26(02):18-22.
点击复制

脊康方在经皮腰椎间孔镜围手术期运用的临床研究()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第26卷
期数:
2018年02期
页码:
18-22
栏目:
病证结合,从督论治
出版日期:
2018-01-15

文章信息/Info

Title:
Clinical Study of Jikang Decoction for Patients with Percutaneous Endoscopic Lumbar Discectomy in Period of Perioperative
文章编号:
1005-0205(2018)02-0018-05
作者:
何升华1 赖居易1 冯华龙2
1广东深圳市中医院骨三病区(广东 深圳,518000) 2广州中医药大学第四临床医学院
Author(s):
HE Shenghua1 LAI Juyi1 FENG Hualong2
1Shenzhen Hospital of Traditional Chinese Medicine,Shenzhen 518033,Guangdong China; 2Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine,Shenzhen 518033,Guangdong China.
关键词:
中药;  脊康方;  微创手术;  腰椎间盘突出症;  督脉
Keywords:
Keywords: traditional chinese medicine;  jikang decoction;  minimally invasive surgery;  lumbar disc herniation;  du meridian
分类号:
R681.5
文献标志码:
A
摘要:
目的:基于“从督论治”的治疗理念探讨脊康方(原方名腰突颗粒)在腰椎间盘突出症患者经皮腰椎间孔镜术围手术期的临床应用价值。方法:选取2015年2月至2016年2月在本病区采用经皮椎间孔镜微创手术治疗的腰椎间盘突出症患者共96例,按随机数字表法分为治疗组、对照组各48例。治疗组在术前3 d及术后1周常规治疗基础上予以口服脊康方煎煮剂; 对照组未口服脊康方煎煮剂。于术前3 d、术后1周、术后2周采用VAS评分、ODI指数、督脉瘀阻症候积分对患者的症状体征进行评价。结果:两组患者术后1周、术后2周VAS评分、ODI指数及督脉瘀阻症候积分均明显优于术前3 d,且差异有统计学意义。治疗组术后1周、术后2周VAS评分及ODI均低于对照组,督脉瘀阻症候积分则高于对照组,差异均有统计学意义(P<0.05)。术后2周治疗组的手术相关并发症为4.17%,低于对照组的14.58%,差异有统计学意义(P<0.05)。结论:通过经皮椎间孔镜微创手术摘除神经根致压物,同时在围手术期口服脊康方补肾通督、活血化瘀、疏通督脉,促进受压神经恢复功能。
Abstract:
Abstract Objective:To investigate the clinical value of Jikang decoction for patients with percutaneous endoscopic lumbar discectomy in period of perioperative based on the concept of “Congdulunzhi”.Methods:A total of 96 patients with lumbar disc herniation underwent percutaneous endoscopic lumbar discectomy surgery in our hospital from February 2015 to February 2016,were selected and randomly divided into treatment group(n=48)and control group(n=48).The patients in the treatment group were given orally Jikang decoction on the basis of routine treatment at 3d before operation and 1 week after operation.The control group was given no oral lumbar granule decoction.The symptoms and signs of the patients were evaluated by VAS score,ODI index and Du stasis syndrome score at 3 d before operation,1 week and 2 weeks after operation.Results:The scores of VAS score,ODI index,and Du stasis syndrome scores at 1 week and 2 weeks postoperatively were significantly better than preoperative 3 d,both of which were significantly different.The ODI and VAS score at 1 week and 2 weeks after operation in the treatment group were lower than that in the control group,and the score of Dukes stasis resistance syndrome was higher than that in the control group,the differences were statistically significant(P<0.05).The rate of complications postoperative was 4.17% in treatment group compared with 14.58% of the control group 2 weeks after operation(P<0.05).Conclusion:Percutaneous endoscopic lumbar discectomy removal of nerve root compression,combined with Jikang decoction in perioperative time can reinforce the kidney and smooth Governor vessel,promote the blood circulation,and promote the recovery of compression nerve root function.

参考文献/References:

[1] 王奕力,李雅竹,杨国彦,等.补充替代医学治疗腰椎间盘突出症的系统评价[J].中华中医药杂志,2017,32(8):3804-3808.
[2] 陈志伟,方晓明,张钰敏,等.倒悬推拿结合火龙灸治疗寒湿型腰椎间盘突出症30例[J].中国中医骨伤科杂志,2017,25(7):62-64.
[3] 杨卫华.独活寄生汤治疗肝肾亏虚腰椎间盘突出症随机平行对照研究[J].实用中医内科杂志,2017,8(10):27-29.
[4] 林仕彬,吴慧,貌杨萍,等.浅谈中医针灸治疗腰椎间盘突出症的临床疗效[J].内蒙古中医药,2017,36(14):107-108.
[5] 王智耀,胡悦,鲁超,等.穴位注射中医综合疗法改善腰椎间盘突出患者生活质量的临床观察[J].世界中西医结合杂志,2017,5(10):1333-1336.
[6] 张华,贾龙,徐斌.腰椎间盘突出症不同证型的手法治疗时间与临床疗效的相关性研究[J].中国中医骨伤科杂志,2017,28(8):25-28.
[7] 汤金泉.中药汤剂联合中医骨伤手法治疗腰椎间盘突出效果观察[J].临床合理用药杂志,2017,10(28):66-67.
[8] 姚啸生,杨鸫祥,张哲,等.中药熨疗治疗腰椎间盘突出症(寒湿痹阻证)多中心随机平行对照临床研究[J].中华中医药学刊,2017,35(10):2600-2603.
[9] 姚乃捷,黄飞麒,赵晓.中医手法配合针灸疗法治疗腰椎间盘突出症的临床研究[J].中国实用医药,2017,12(24):35-36.
[10] 符慧明,陆志夫,朱华亮,等.中医针灸结合正骨推拿治疗单纯性腰椎椎间盘突出症的临床观察[J].辽宁中医杂志,2017,44(9):1951-1953.
[11] 罗莎,李军文.中医治疗腰椎间盘突出症的研究进展[J].江苏中医药,2017,49(8):83-86.
[12] 谌德雄,高杏.自拟逐瘀止痛方联合手法正骨治疗腰椎间盘突出症临床研究[J].时珍国医国药,2017,28(9):2177-2179.
[13] 胡月.综合方法治疗腰椎间盘突出症临床观察[J].实用中医药杂志,2017,33(11):1311-1312.
[14] 移平,谭明生.督脉瘀阻型寰枢椎脱位手术联合中药治疗的临床研究[J].中国中医骨伤科杂志,2017,25(1):15-19.
[15] 何洪艳.中医治疗腰椎间盘突出症的新进展[J].北方药学,2013,5(5):49-50.
[16] 国家中医药管理局医政司.中医病证诊断疗效标准[J].湖北中医杂志,2002(2):57.
[17] 谭明生,李显.寰枢椎脱位外科治疗与疏通督脉瘀阻相关性研究[J].中国骨伤,2012,25(11):915-919.
[18] 贾峻.腰椎间盘突出症中医治疗述要[J].医学信息,2016,29(4):187-188.
[19] 李杰.余氏通督补肾疗法治疗腰痛病的临床观察[J].中外医学研究,2016,14(14):122-124.
[20] 朱金华.定位注射加督脉经手法治疗腰脊神经后支综合征[J].中医正骨,2001,9(13):29.
[21] 赵晓.腰椎间盘突出症的中医治疗及辨证施护[J].甘肃医药,2015,34(5):361-363.
[22] 谭明生.对寰枢椎脱位的手术适应证与外科治疗原则的思考[J].中国骨伤,2012,25(1):1-3.
[23] 卢卫.腰段督脉电针治疗腰椎间盘突出症的临床研究[J].中国临床康复,2002,6(8):1164-1165.
[24] 胥林波.督脉与脊髓的关系探析[J].现代中西医结合杂志,2011,20(30):3844-3845.
[25] 焦顺发.督脉是脊髓浅识[J].中国针灸,2006,26(10):761.
[26] 谭明生,齐英娜.球囊导管构建大鼠督脉瘀阻型上颈脊髓损伤模型的研究[J].中医正骨,2016,28(12):881-885. (收稿日期:2017-09-11)

备注/Memo

备注/Memo:
基金项目:广东省中医药局科研项目(20162126) 深圳市知识创新基础研究项目 (JCYJ201504011163247232) 深圳市知识创新基础研究项目 (JCYJ20170307155040463)
更新日期/Last Update: 2018-02-15